The clinical significance of pharmacogenetic biomarkers OPRM1 rs1799971, COMT rs4680 and ABCB1 (rs1045642, rs1128503, and rs2032582) should be further explored in future studies to improve precision pain management amongst Asian patients with cancer pain. Here, OPRM1 is linked to cancer.